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Objectives. The aim of this study was to assess the possible value of a polytetrafluoroethylene (PTFE) patch in the treat-
ment of recurrent varicose veins.
Methods. Thirty-one patients (40 legs) with recurrent saphenofemoral junction incompetence were randomised to redo
saphenofemoral ligation and great saphenous vein stripping with, or without the insertion of a PTFE patch over the ligated
junction. Patients underwent assessment preoperatively, and at 6 weeks, 1 year and 2 years postoperatively with clinical
examination, duplex imaging and completion of the Aberdeen Varicose Vein Symptom Severity Score (AVVSSS).
Results. A total of 27 patients (32 legs) attended for assessment at 6 weeks, 25 patients (30 legs) at 1 year and 27 patients
(32 legs) at 2 years. At 6 weeks, seven legs (22%) had an area of cutaneous numbness; all but one had resolved by 1 year.
Four legs (13%) developed a groin infection, which required antibiotics, 2 had a groin haematoma and four had a seroma,
all of which resolved spontaneously. The overall complication rate was 35% (11 legs), with no statistically significant dif-
ference between the groups. Four of 16 legs without a patch and five of 16 legs with a patch developed neovascularisation at
the saphenofemoral junction on duplex imaging by two years postoperatively. Two cases of neovascularisation in the patch
group and one in the no patch group directly resulted in clinical recurrence (p¼ 1.0). There was an improvement in
patients’ AVVSSS two years postoperatively (p< 0.03), that was similar in both groups.
Conclusions. In this study, insertion of a PTFE patch did not affect the rate of perioperative complications and it did not
appear to contain neovascularisation.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Surgery for recurrent varicose veins is thought to have
a higher recurrence rate than surgery for primary
veins.1,2 The optimal treatment for symptomatic or
complicated recurrent varicose veins has yet to be
defined. The commonest cause of recurrent veins is
failure at the level of the groin dissection. This
may be due to inadequate primary surgery3,4 or the
development of new vesselseneovascularisation.1,5e7
A number of barrier techniques aimed at containing
neovascularisation have been published.2,8e12 Gibbs
et al. performed a randomised trial using a flap of pec-
tineus fascia but showed no reduction in re-recurrence
rates.13 There have been no randomised trials using
a synthetic patch.
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investigated the use of a Polytetrafluoroethylene
(PTFE) patch inserted into the groin of patients under-
going surgery for recurrent varicose veins.10 It showed
the technique to be safe and appeared to show rela-
tively low re-recurrence rates. Based on these findings
a randomised controlled trial was undertaken.
Patients and Methods
This study was performed by a single surgical team at
Gloucestershire Royal Hospital and was approved by
the Local Hospital Ethics Committee.
All patients seen in surgical outpatients and listed
for redo saphenofemoral ligation, great saphenous
vein (GSV) stripping and multiple phlebectomies
between April 2003 and February 2005 were invited
to take part in the study. Those with concomitant sap-
henopopliteal disease were excluded. Patients were
given a study information leaflet; all eligible patientslar Surgery. Published by Elsevier Ltd. All rights reserved.
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consent.
Patients underwent assessment pre-operatively
and at 6 weeks, 1 year and 2 years postoperatively
with clinical examination, duplex imaging and com-
pletion of the Aberdeen Varicose Vein Symptom Se-
verity Score (AVVSSS).14,15 Complications of surgery
were documented at the 6-week follow-up appoint-
ment and patients were asked to comment on their
degree of satisfaction with the surgery at each
follow-up. Recurrent varicose veins were defined as
any new visible varicosity on clinical examination at
1 and 2 years postoperatively.
Randomisation was performed using sealed enve-
lopes and the random number generator with varying
block sizes in SPSS version 11.5. Envelopes were
opened on, or as close as possible to the day of surgery.
Patients rather than individual legs were randomised,
therefore those with bilateral recurrent varicose veins
had the same procedure performed on both legs.
Duplex imaging was performed in the vascular lab-
oratory using an ATL HDI 5000 colour duplex scanner
with a 4e7 Mhz linear array transducer. Patients un-
derwent scanning in a sitting position with their
legs dependent. Reflux of greater than one second
after manual calf compression was taken to diagnose
incompetence. Valsava’s manoeuvre was performed
if no reflux was detected with calf compression. A
whole-leg duplex scan was undertaken with docu-
mentation of any reflux in the deep and superficial
veins. All named vessels and their variants were as-
sessed and varicosities mapped. Neovascularisation
was defined as the presence of serpentine venous
tributaries entering the common femoral vein at the
site of the old saphenofemoral junction after calf
compression or Valsava’s manoeuvre. A clinical grad-
ing system was used to describe the degree of
neovascularisation.6,10
Grade 0: no neovascularisation
Grade 1: <3 mm diameter vessels
Grade 2: >3 mm diameter vessels with visible reflux
No comment was consistently made on the size of
the tributaries. Incompetent perforating veins were
defined as those with bi-directional flow on calf
compression. The patch was not usually visible on
follow-up imaging, so technologists were blinded to
the intervention received.
All operations were performed under general an-
aesthetic by, or under the supervision of a single con-
sultant vascular surgeon (present and scrubbed at all
procedures performed) (Table 1). Groin re-exploration
involved extension of the original groin crease
Eur J Vasc Endovasc Surg Vol 34, September 2007incision with a standard lateral approach, first identi-
fying the common femoral artery and then dissecting
medially towards the common femoral vein (CFV),
approaching the saphenofemoral junction (SFJ) from
below. Re-ligation was performed using a C-clamp
on the CFV to avoid narrowing and a running 5/0 pro-
lene suture was used to oversew the SFJ. The CFV was
exposed over a further 2e3 cm and any tributaries
divided. Patients randomised to PTFE patch insertion
had a 3 2 cm tailored PTFE patch sutured over the
ligated junction using two lateral 3/0 polyglycolic
acid sutures (Fig. 1). The groin wound was soaked
in povidone-iodine prior to closure with 2 layers of
3/0 polyglycolic acid sutures. The residual GSV
was either stripped or ablated with sequential
phlebectomies.
The primary outcome measure was clinical recur-
rence (any new visible varicosity) at 2 years following
surgery. The secondary outcome measure was the
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Fig. 1. PTFE patch in-situ. Overlying the common femoral
vein.





participate (n = 0)
Other reasons
(n = 0)
Allocated to PTFE patch
(n = 15 patients (20 legs))
Received allocated intervention
(n = 13 patients (17 legs))
Did not receive allocated intervention
(n = 2 patients (3 legs))
Reasons - 1 patient (2 legs) had
treatment in another hospital
1 leg: foam sclerotherapy
Allocated to no PTFE patch
(n = 16 patients (20 legs))
Received allocated intervention
(n = 16 patients (17 legs))
Did not receive allocated intervention
(n = 3 patients (3 legs))
Reasons - 2 legs: reverse strip GSV
only
1 leg: saphenopopliteal incompetence
Lost to follow up: (n = 1 leg) 
Follow up at 6 weeks, 1 year and
2 years and analysed (n = 16 legs) 
Follow up at 6 weeks (n = 16 legs),
follow up at 1 year (n = 14 legs),
follow up at 2 years (n =  16 legs) and
analysed
Randomised
(n = 31 patients (40 legs))
Lost to follow up: 6 weeks (n = 1 leg),
1 year and 2 years (n = 1 legs)
Assessed for eligibility
(n = 31 patients (40 legs))
Fig. 2. Flow of patients through trial.presence of neovascularisation at the SFJ 2 years
following surgery. The other outcome measures in-
cluded complication rates, patient satisfaction, and
quality of life data.
Sample size was calculated on the basis of the pri-
mary outcome measure: clinical recurrence at 2 years
following surgery. Based on the pilot study, use of
a PTFE patch resulted in a clinical recurrence of
25%.2 The figures for re-recurrence without a patch
are limited, however, a reduction in re-recurrence
from 50% to 25% was used to calculate a sample
size of 56 legs per group to be appropriate for a power
of 0.8 and a a¼ 0.05.Clinical data were compared with Fisher’s exact
test and AVVSSS scores were compared using the
Mann-Whitney U test.
Results
A total of 31 patients (40 legs) were recruited between
April 2003 and February 2005. Fifteen patients (20
legs) were randomised to receive insertion of a PTFE
patch following re-ligation of the SFJ. Sixteen patients
(20 legs) were randomised to receive re-ligation of the
SFJ without PTFE patch insertion. Three legs in each
Eur J Vasc Endovasc Surg Vol 34, September 2007
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legs had reverse stripping of the GSVonly, 1 had addi-
tional saphenopopliteal incompetence, 1 had foamscle-
rotherapy and 1 completed their treatment in another
hospital). One leg in each group was lost to follow-up
at the 6-week follow-up appointment. In the patch
group, 3 legs were lost to follow-up at 1 year and 1 leg
at 2 years; 1 leg was lost to follow-up at 1 and 2 years
in the no patch group (Fig. 2).
Clinical and operative characteristics are shown in
Table 2.
6-week follow up
Twelve patients (16 legs) in the patch group and fifteen
patients (16 legs) in the no patch group attended early
follow-up. Two legs in each group developed a post-
operative groin wound infection requiring antibiotics.
A total of 4 legs developed a seroma, 3 in the patch
group e all settled spontaneously. Two legs in each
group developed a groin infection. Three legs devel-
oped a groin haematoma, 1 lead to a groin infection.
No patches had to be removed. Four legs in the patch
groupand3 in thenopatchgroupdeveloped cutaneous
numbness. All but one settled by one year postopera-
tively. One patient in each group was unhappy with
the results of surgery. The patient in the patch group
had residual varicose veins bilaterally and developed
a wound infection of the right groin. The patient in
the no patch group had a groin wound infection.
Quality control duplex imaging at 6 weeks post-
operatively revealed no incompetent, intact sapheno-
femoral junctions. One leg in the patch group had
a small but competent anterior thigh vein connecting
with the common femoral vein. There were 7 legs in
which an incompetent vessel remained present in the
upper thigh. (5 patch, 2 no patch). In each case the op-
eration note stated ‘unable to locate GSV’, ‘GSV strip-
ped to knee’, ‘failed to strip GSV e avulsed only’. In
four cases it stated ‘thigh and calf avulsions only’.
In three legs there were small amounts of incompetent
flow in short sections of superficial thigh vessels.







Mean Age (range) 58 (27e83) 50 (30e67)
Sex (M: F) 5:11 3:12
Bilateral: Unilateral 4:12 5:10
Left: Right 11:9 9:11
C of CEAP classification
C2-C3:C4-C5
11:9 14:6
Day-case: Inpatient 10:6 6:9
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Ten patients (14 legs) in the patch group and fifteen
patients (16 legs) in the no patch group attended
follow-up at 1 year postoperatively. Recurrent varicose
veins were visible in 7 legs in the patch group and
4 legs in the no patch group (p¼ 0.26). Thigh varicosi-
ties were visible in 5 legs in the patch group, but only
one leg in the no patch group (p¼ 0.17).
Duplex imaging showed grade 2 neovascularisa-
tion in 3 legs in the patch group, and 1 leg in the no
patch group (p¼ 0.32). A further 2 legs in the no patch
group had grade 1 neovascularisation. Neovascular-
isation directly accounted for one case of recurrence
in the patch group.
All patients in the no patch group and 71% of pa-
tients in the patch group were happy with the results
of surgery (p¼ 0.04).
2-year follow up
Twelve patients (16 legs) in the patch group and fif-
teen patients (16 legs) in the no patch group attended
follow-up at 2 years postoperatively. Recurrent vari-
cose veins were visible in 8 legs in the patch group
and 4 legs in the no patch group (p¼ 0.27) (Fig. 3).









Fig. 3. (a): Recurrence rates for no PTFE patch group at
2 year follow-up (b): Recurrence rates for PTFE patch group
at 2 year follow-up.
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the no patch group (Grade 1 - 2 legs, grade 2 - 2 legs)
(p¼ 1.0). Neovascularisation was the cause of recur-
rence in 2 legs in the patch group and 1 leg in the
no patch group (p¼ 1.0).
The remaining clinical recurrences in the patch
group were due to incompetent superficial thigh
tributaries from the upper thigh in 4 legs, incompetent
vessels emanating from the pelvis in two legs and an
incompetent mid-thigh perforator in 1 leg. In 3 of
these legs the incompetent thigh vessels were not
present on the 6-week follow-up duplex assessment.
Eight patients (9 legs, 56%) in the patch group and
fourteen patients (88%) in the no patch group re-
mained happy with the results of surgery (p¼ 0.11).
Quality of life analysis
There was no statistically significant difference in
AVVSSS between the patch group and the no patch
group at any time point. There was a statistically sig-
nificant improvement in AVSSS at 6 weeks, 1 year and
2 years following surgery for both groups (Table 3).
Discussion
Recurrent varicose veins are often due to failure at the
level of the groin dissection. Until recently, inadequate
surgery was held to be the culprit, however, the ad-
vent of duplex imaging and histological analysis of
specimens have suggested that neovascularisation is
the commonest cause.6,7,16,17 A significant amount of
research has been aimed at decreasing recurrent groin
reflux. Barrier techniques have been used by a number
of authors. Sheppard was the first to describe the use
of an anatomical barrier, in the form of a reflected flap
of pectineus fascia.8 The flap procedure was per-
formed on over 2000 patients with primary and recur-
rent varicose veins. Unfortunately only 93 patients
were followed up. Two developed recurrent thigh
varicosities and had further surgery. Gibbs et al. fur-
ther assessed the use of a pectineal flap in a rando-
mised trial of patients with recurrent varicoseveins.13 They showed no difference in re-recurrence
rates or neovascularisation rates between the two
groups. Their findings may, however, represent
a Type 2 error, as the numbers were small (20 legs
in each group). Glass pioneered the use of a synthetic
barrier in the form of a synthetic mesh (Mersilene,
Ethicon Ltd).9,18 He showed a SFJ recurrence rate of
1% at a mean of 5 years following surgery. One patient
required mesh removal due to infection. In view of
this Glass changed to a silicone patch, but no
follow-up results were published. De Maeseneer in
Belgium has performed work based on that started
by Glass, in the form of two non-randomised trials
of silicone patch implantation for primary and recur-
rent veins.12,19 The five year follow-up data for those
in the recurrent veins study showed that the use of
a silicone patch reduced the rate of re-recurrence
from 58% to 26% and the rate of grade 2 neovascular-
isation from 45% to 9%.
PTFE was first used by Creton between April 1992
and June 1994.11 119 patients with recurrent varicose
veins underwent redo saphenofemoral ligation fol-
lowed by insertion of a PTFE patch (11.5 cm),
which was glued, to the CFV. Follow up at a mean
of 4.9 years showed a neovascularisation rate of 4%.
The use of a synthetic patch was first explored by
the authors in 1997.2 PTFE was chosen for it’s lack
of porosity and well known safety profile as a conduit
for arterial bypass surgery. A pilot study involving
patients with primary and recurrent veins showed
that use of the patch was safe. Those undergoing sur-
gery for recurrence had disappointing results with
a recurrence rate of 47% (7 of 15 legs) and neovascu-
larisation rate of 40% (6 of 15 legs). Recognising the
possible learning curve, a further 80 legs with recur-
rent veins underwent patch insertion and the recur-
rence rates and neovascularisation rates at a median
of 19 months following surgery were 23% and 37%
respectively.6 Neovascularisation remained the com-
monest source of recurrence and therefore the size
of the patch was increased to 3 2 cm. This study
was set up in order to assess the role of the PTFE
patch objectively in a blinded, randomised trial. Every





Patch group (Mean  SD) p-value for comparison
with baseline score
Preoperative AVVSSS 21  8 21  5
6 week AVVSSS 13  10 P ¼ 0.008 10  7 P ¼ 0.006
1 year AVVSSS 10  9 P ¼ 0.001 10  9 P ¼ 0.013
2 year AVVSSS 10  7 P ¼ 0.002 12  13 P ¼ 0.028
P - values equal level of significance of difference from baseline score for each group at each follow up point.Eur J Vasc Endovasc Surg Vol 34, September 2007
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tion) with the gold standard procedure for recurrent
varicose veins. Unfortunately the trial was discontin-
ued early as foam sclerotherapy took over as the treat-
ment of choice for recurrent veins. This left only
a small number of legs in each group. There was no
statistically significant difference in recurrence rates
or neovascularisation rates, in fact the rates were
higher in the patch group. The higher rates in the
patch group may have occurred due to a failure ade-
quately to secure the position of the patch or alterna-
tively the larger size may have acted as a stimulus to
neovascularisation. Previous studies have shown a
decrease in recurrence and neovascularisation when
using a synthetic patch.11,12 These were unexpected
results but it is difficult to draw any firm conclusions
as they may represent a type 2 error related to the
small sample size.
The higher rates of recurrence in the patch group
may be due to failure to remove all of the superficial
thigh vessels at the time of surgery. Whilst all patients
underwent preoperative duplex assessment, no intra-
operative imaging was performed. This may have im-
proved the results. The early complications related to
PTFE patch insertion were similar to those described
by De Maesseneer et al. in relation to a Silicone
patch.20 They also described late complications in
the form of 4 late groin infections and 4 cases of
CFV stenosis. Their case mix included patients with
primary and recurrent varicose veins. In some cases
performed for recurrence, the patch was sutured di-
rectly on to the CFV. This may have been the cause
of the stenosis. The authors did not identify any cases
of late infection or stenosis in their cohort of patients.
The high incidence of complications related to redo
groin surgery has caused some to argue that it is
unnecessary to re-operate in the groin. Mitton et al.
describe the technique of retrograde stripping of the
GSV.21 The authors have used this technique in other
patients where there was no clear neovascular saphe-
nofemoral junction leading to reflux. Unfortunatelyno
follow-up studies have been performed to assess this
approach formally. In this study there was failure to
strip the GSV in 11 legs in each group (although at-
temptsweremade to performmultiple phlebectomies).
Preoperative marking of the GSV was not used at this
time. All those who developed re-recurrence due to
neovascularisation were in this group.
Despite an improvement in AVVSSS following sur-
gery the early results from this trial lead to a change in
practice in the author’s unit. In 2005, foam sclerother-
apy became the first line treatment for recurrent vari-
cose veins. The failure to recruit the number of legs
required to show a meaningful difference between
Eur J Vasc Endovasc Surg Vol 34, September 2007the groups relates to the introduction of this technique.
Foam sclerotherapy negates the need to re-explore the
groin and the associated duplex guidance ensures that
all varicosities are treated. It can be performed on an
outpatient basis and appears to be a safe technique
in those who are appropriately trained.22,23 Endo-
venous laser and radiofrequency treatments are also
possible options if there is a clearly visible residual
GSV or large anterior thigh vein.
Until the intricacies of the neovascular process are
determined and patients with a propensity to its de-
velopment can be identified and treated, endovenous
treatments may play an increasing role in the manage-
ment of recurrent varicose veins.
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